|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of tangible goods sold | |||||
| Cost of goods sold - idle capacity | |||||
| Gross loss | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Impairment of assets, net | |||||
| Loss on impairment of property and equipment | |||||
| Loss on impairment of other assets | |||||
| Other income | |||||
| Operating loss | |||||
| Change in value of conversion feature senior notes | |||||
| Change in value of Series B warrants | |||||
| Change in value warrants, senior convertible notes | |||||
| Gain on deposit for technology license | |||||
| Change in value of senior warrants, loss | |||||
| Debt discount amortization expense | |||||
| Interest expense, notes payable | |||||
| Extinguishment loss on senior notes conversion | |||||
| Loss on extinguishment subordinated notes | |||||
| Derivative revaluations (gain) loss | |||||
| Placement agent warrants | |||||
| Interest expense on convertible notes | |||||
| Loss before income taxes | |||||
| Income taxes | |||||
| Net loss | |||||
| Foreign translation adjustment | |||||
| Comprehensive loss | |||||
| Basic and diluted net loss per share (in dollars per share) | |||||
| Basic and diluted weighted average common shares outstanding (in shares) | |||||
Loading...